Pharmaceutical Business Environment Update: MEA

BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets. In particular we highlight Saudi Arabia, Egypt and Ghana as the most positive and promising, while the UAE and South Africa will continue as the main investment focus. We underline that Ghana, newly added to our ratings, has entered at a respectable regional ranking of 15th out of 19. In MEA terms, this is quite low, but in terms of our sub-Saharan African market coverage, only South Africa has a higher score

To read the full article, please choose one of the following options: